Evidence map›Paper›PMID 38041701›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2023

β-Sitosterol Alleviates Neuropathic Pain by Affect Microglia Polarization through Inhibiting TLR4/NF-κB Signaling Pathway.

Yachun Zheng, Jiaji Zhao, Shiquan Chang, Zifeng Zhuang, Si Waimei, Xin Li, Zenni Chen, Bei Jing, Di Zhang, Guoping Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. TLR4 induced TRPM2 mediated neuropathic pain.Frontiers in pharmacology · 2024
    Review
  16. Article
  17. Phytochemical Analysis and Anti-Inflammatory Potential ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yachun ZhengCollege of Traditional Chinese Medicine, Jinan University, Tianhe District, West of Huangpu Road No. 601, Guangzhou, 510632, China.
Jiaji ZhaoChemistry & Chemical Engineering, Guangdong Pharmaceutical University, Guangzhou, China.
Shiquan ChangCollege of Traditional Chinese Medicine, Jinan University, Tianhe District, West of Huangpu Road No. 601, Guangzhou, 510632, China.
Zifeng ZhuangCollege of Traditional Chinese Medicine, Jinan University, Tianhe District, West of Huangpu Road No. 601, Guangzhou, 510632, China.
Si WaimeiCollege of Traditional Chinese Medicine, Jinan University, Tianhe District, West of Huangpu Road No. 601, Guangzhou, 510632, China.
Xin LiCollege of Traditional Chinese Medicine, Jinan University, Tianhe District, West of Huangpu Road No. 601, Guangzhou, 510632, China.
Zenni ChenCollege of Traditional Chinese Medicine, Jinan University, Tianhe District, West of Huangpu Road No. 601, Guangzhou, 510632, China.
Bei JingCollege of Traditional Chinese Medicine, Jinan University, Tianhe District, West of Huangpu Road No. 601, Guangzhou, 510632, China.
Di ZhangCollege of Traditional Chinese Medicine, Jinan University, Tianhe District, West of Huangpu Road No. 601, Guangzhou, 510632, China. zhangdi0915@126.com.
Guoping ZhaoCollege of Traditional Chinese Medicine, Jinan University, Tianhe District, West of Huangpu Road No. 601, Guangzhou, 510632, China. tguo428@jnu.edu.cn.
Jinan University · CNGuangdong Pharmaceutical University · CN

Funding

Technology Innovation Team project of Guangdong Provincial Drug AdministrationJiaji Zhao S2021TDZ085
6 · The paper itself

Abstract

The etiology of neuropathic pain is mostly caused by mechanical deformation and neuroinflammation, of which neuroinflammation is the main cause of chronic neuropathic pain. Activation of the TLR4/NF-κB signaling pathway mediates elevated levels of inflammatory cytokines, and we clearly demonstrated by in vivo and in vitro Western blot experiments that β-sitosterol significantly inhibited the elevated Toll-like receptor 4 (TLR4) expression levels and nuclear factor-kappa B (NF-κB) activation associated with inflammatory responses. In cellular experiments, we clearly saw that both β-sitosterol and TLR4/NF-κB signaling pathway inhibitors could inhibit M1 proinflammatory phenotype expression and promote M2 anti-inflammatory phenotype expression in GMI-R1 microglia by flow cytometry and immunofluorescence assays. Therefore, we suggest that β-sitosterol can affect microglial polarization by inhibiting the TLR4/NF-κB signaling pathway thereby reducing neuroinflammation and thus alleviating neuropathic pain.

Indexed as

NeuralgiaNF-kappa BHumansMicrogliaNeuroinflammatory DiseasesSignal TransductionSitosterolsToll-Like Receptor 4gamma-sitosterolNF-kappa BSitosterolsTLR4 protein, humanToll-Like Receptor 4GMI-R1InflammationNF-κBSciaticaTLR4β-Sitosterol

Identifiers

PMID38041701
OpenAlexW4389264154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.